NASDAQ:MBRX
Moleculin Biotech, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.moleculin.comipo date
Jun 02, 2016
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/tr...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus